Ma D - Search Results

1

The Impact of Medication Regimen Adjustment Ratio on Adherence and Glycemic Control in Patients with Type 2 Diabetes and Mild Cognitive Impairment.

Song X, Wu J, Yang Y, Xu W, Shi X, Dong K, Li M, Chen X, Wang Y, Bian X, Gao L, Yu X, Ma D, Tao J. Song X, et al. Among authors: ma d. Biomedicines. 2024 Sep 16;12(9):2110. doi: 10.3390/biomedicines12092110. Biomedicines. 2024. PMID: 39335623 Free PMC article.

2

Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes.

Yang Y, Ma D, Wang Y, Jiang T, Hu S, Zhang M, Yu X, Gong CX. Yang Y, et al. Among authors: ma d. J Alzheimers Dis. 2013;33(2):329-38. doi: 10.3233/JAD-2012-121294. J Alzheimers Dis. 2013. PMID: 22936005

3

A meta-analysis of salicylates for type 2 diabetes mellitus.

Fang F, Lu Y, Ma DL, Du TT, Shao SY, Yu XF. Fang F, et al. J Huazhong Univ Sci Technolog Med Sci. 2013 Feb;33(1):1-14. doi: 10.1007/s11596-013-1063-5. Epub 2013 Feb 8. J Huazhong Univ Sci Technolog Med Sci. 2013. PMID: 23392700 Review.

4

Association of the ADRA2A polymorphisms with the risk of type 2 diabetes: a meta-analysis.

Chen X, Liu L, He W, Lu Y, Ma D, Du T, Liu Q, Chen C, Yu X. Chen X, et al. Among authors: ma d. Clin Biochem. 2013 Jun;46(9):722-6. doi: 10.1016/j.clinbiochem.2013.02.004. Epub 2013 Feb 24. Clin Biochem. 2013. PMID: 23462695

5

Subcutaneous administration of liraglutide ameliorates Alzheimer-associated tau hyperphosphorylation in rats with type 2 diabetes.

Yang Y, Zhang J, Ma D, Zhang M, Hu S, Shao S, Gong CX. Yang Y, et al. Among authors: ma d. J Alzheimers Dis. 2013;37(3):637-48. doi: 10.3233/JAD-130491. J Alzheimers Dis. 2013. PMID: 23948890

6

Short-term effects of continuous subcutaneous insulin infusion therapy in perioperative patients with diabetes mellitus.

Ma D, Chen C, Lu Y, Ma J, Yin P, Xie J, Yang Y, Shao S, Liu Z, Zhou X, Yuan G, Yu X. Ma D, et al. Among authors: ma j. Diabetes Technol Ther. 2013 Dec;15(12):1010-8. doi: 10.1089/dia.2013.0117. Epub 2013 Aug 24. Diabetes Technol Ther. 2013. PMID: 23971526 Free PMC article.

7

The changes of leukocyte telomere length and telomerase activity after sitagliptin intervention in newly diagnosed type 2 diabetes.

Ma D, Yu Y, Yu X, Zhang M, Yang Y. Ma D, et al. Diabetes Metab Res Rev. 2015 Mar;31(3):256-61. doi: 10.1002/dmrr.2578. Epub 2014 Sep 2. Diabetes Metab Res Rev. 2015. PMID: 25044768 Clinical Trial.

8

Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.

Xu W, Yang Y, Yuan G, Zhu W, Ma D, Hu S. Xu W, et al. Among authors: ma d. J Investig Med. 2015 Feb;63(2):267-72. doi: 10.1097/JIM.0000000000000129. J Investig Med. 2015. PMID: 25479064

9

Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysis.

Lu Y, Ma D, Xu W, Shao S, Yu X. Lu Y, et al. Among authors: ma d. J Diabetes Investig. 2015 Jan;6(1):78-86. doi: 10.1111/jdi.12246. Epub 2014 Jun 18. J Diabetes Investig. 2015. PMID: 25621136 Free PMC article.

10

Early intervention with glucagon-like peptide 1 analog liraglutide prevents tau hyperphosphorylation in diabetic db/db mice.

Ma DL, Chen FQ, Xu WJ, Yue WZ, Yuan G, Yang Y. Ma DL, et al. J Neurochem. 2015 Oct;135(2):301-8. doi: 10.1111/jnc.13248. Epub 2015 Aug 11. J Neurochem. 2015. PMID: 26183127 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,757 results

Search Page

Filters